Trial Sponsor: Carmot Therapeutics, Inc. Why is this study important? This study is investigating the effects of CT-868, a once-daily injectable GLP-1/GIP receptor agonist, in people with type 1 ...

Journavx is the first of a new class of non-opioid pain medications FDA-approved for treating moderate-to-severe acute pain in adults. A new medication is on the horizon for adults dealing with acute ...

Best-selling author and diaTribe contributor Jim Hirsch shares his experience trying out the first over-the-counter CGMs to hit the market. 2024 was a breakthrough year for continuous glucose ...

Spinal cord stimulation can be an effective treatment for managing pain associated with diabetic peripheral neuropathy, especially if other therapies have been ineffective. Following a trial period, ...

Unlike FDA-approved GLP-1 medications like Ozempic and Wegovy, dietary supplements like Lemme GLP-1 Daily do not require FDA approval or any data to support their marketing claims. Limited research ...

Initial results of Sana Biotechnology’s new gene-editing technique demonstrate that transplanted islet cells successfully produced insulin in one individual with type 1 diabetes – without the need for ...

Fully closed loop systems take automated insulin delivery a step further by skipping meal announcements. People with diabetes in the open source community are using fully closed loop systems, and ...

Blue Circle Health is a free, six-month program that offers virtual care to people with type 1 diabetes. The service provides comprehensive support in one place, including telehealth, diabetes ...

Intuitive eating is a practice that integrates instinct, emotion, and rational thought to help individuals connect with their body and build a healthier relationship with food. Studies have shown that ...

Why is this study important? Sotagliflozin is an SGLT-2 inhibitor approved to treat type 2 diabetes, heart failure, and chronic kidney disease. Specifically, the medication has been shown to prevent ...

With so many things happening in the diabetes tech world, it can be hard to keep up. Stay up to date here with the latest diabetes tech news and alerts. The FDA has issued a warning that users of ...

SGLT-2 inhibitors are a type of oral medication that people with type 2 diabetes can use to lower blood sugar levels. How do SGLT-2 inhibitors work to lower blood sugar As our kidneys filter our blood ...